Navigation Links
AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode
Date:10/22/2014

SAN DIEGO, Oct. 22, 2014 /PRNewswire/ -- AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 (k) OTC clearance by the U.S. Food and Drug Administration. This clearance allows the AVACEN 100 to be marketed over the Internet for: the temporary relief of joint pain associated with arthritis; muscle spasms; and minor strains and sprains.

Logo - http://photos.prnewswire.com/prnh/20141021/153513

The AVACEN 100 (MSRP $2495) is a sophisticated medical device incorporating over 3,000 firmware instructions supporting  numerous innovations including an internal 'Game Mode.' This mode encourages users to complete their 10-30 minute therapy session, and also allows a therapist to monitor for proper device use during self-administered therapy.

"We designed this feature for a family member with attention challenges. The goal was to help him remain engaged while completing an unexciting 20-minute therapy session. Later we determined that this was also an ideal way to monitor the unattended use by therapy patients. In 'normal' mode, the device automatically turns off at the end of each session. In 'Game Mode,' the therapist can simply look at the points accumulated to determine if the device was properly used," said Thomas G. Muehlbauer, Chairman and CEO, AVACEN Medical. 

Optional Game Mode awards real-time points when the user keeps their hand properly positioned on the hand pad during the therapy session. Accumulated points are shown on the display panel. The better the hand position, the more points earned. If the patient's hand drifts too far off target, an alarm goes off and 10,000 points are lost.

At the end of the therapy session the final score is displayed, along with the previous high score and a random encouragement message that relates to the performance achieved e.g. "Major league performance! Wow."

About the AVACEN 100: In March of 2014 the US Patent Office issued Patent No. 8,679,170 to AVACEN covering key aspects of the medical technology platform integrated in the AVACEN 100.

The issued patent includes apparatus claims directed to features of the Heat Therapy apparatus manufactured by AVACEN and method claims directed to specific methods of use, referred to by the company as the AVACEN Treatment Method.  The patent also covers innovations embodied in the AVACEN 100 system, which is expected to allow multiple therapeutic uses to alleviate symptoms associated with a circulatory, neurological, lymphatic, or endocrinal dysfunction, or any combination thereof.

About AVACEN: AVACEN Medical is dedicated to the innovation and design of safe, easy-to-use, and noninvasive drug free alternatives to treat pain associated with diseases such as arthritis, fibromyalgia and migraines. Founded in 2009, AVACEN is headquartered in San Diego. Contact: Ryan Jeffcoat at (888) 4-AVACEN x 711 or Email.


'/>"/>
SOURCE AVACEN Medical
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2018)... ... November 29, 2018 , ... ... announced today the launch of the Annatto-E™ product line, containing unique and natural ... by clinical research, DFH’s new Annatto-E™ products are available in three dosages of ...
(Date:11/29/2018)... ... November 29, 2018 , ... ... unique product makes the company’s powerful electronic forms and eSignatures functionality accessible via ... by leaps and bounds in the consumer space and it’s about time hospital ...
(Date:11/28/2018)... , ... November 28, 2018 , ... ... to Israel’s Sheba Medical Center, Tel HaShomer this week to form a collaboration ... his home country, the Democratic Republic of Congo. , On Thursday, November ...
Breaking Medicine Technology:
(Date:12/6/2018)... ... December 06, 2018 , ... ... disease schistosomiasis significantly faster than the drug most commonly used against the ailment—and ... Republic of Congo. The study’s authors, including a professor and two research associates ...
(Date:12/5/2018)... ... 05, 2018 , ... Adam Devlin , co-founder and ... serve on Philadelphia Mayor James F. Kenney’s Commission on People with Disabilities. The ... a cognitive or physical disability. Devlin serves as the chair of the Behavioral ...
(Date:12/5/2018)... , ... December 05, 2018 , ... A well-known name ... fitness content to the masses. Wellbeats , which has delivered on-demand, virtual fitness ... new Wellbeats consumer app. Available now in the Apple App Store, the Wellbeats ...
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... Since ... silicone ruptures. The implants are invisible to the naked eye, ensuring a natural look. ... centered and that there are no signs of implant visibility,” says Dr. Jessica Kulak, ...
(Date:12/5/2018)... ... , ... Domenic Palmieri has been named chief operating officer ... for the executive oversight of operations for three core divisions within HM, including ... position,” Tom Doran, president, HM Insurance Group, said. “And while we had significant ...
Breaking Medicine News(10 mins):